2Mandell LA. Update on community-acquired pneumonia. New pathogens and new concepts in treatment. Postgrad Med ,2005,118:35-46.
3Schwartz DN, Furumoto-Dawson A, Itokazu GS, et al. Preventing mismanagement of community-acquired pneumonia at an urban public hospital:implications for institution-specific practice guidelines. Chest, 1998,113 ( Suppl 3 ) : 194S- 198S.
4Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis ,2007,44( Suppl 2 ) : S27-S72.
5American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and heahhcare-associated pneumonia. Am J Respir Crit Care Med,2005,171: 388-416.
6Hospital-acquired pneumonia in adults : diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med, 1996, 153:1711-1725.
7Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J ,2005,26 : 1138-1180.
8Owens RC Jr, Ambrose PG, Nightingale CH. Antibiotic Optimization. Concepts and Strategies in Clinical Practice. New York : Marced Dekker, 2005,491-518.
9El Moussaoui R, de Borgie CA, van den Broek P, et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ ,2006,332 : 1355.
10D1gnazio J,Camere MA,Lewis DE ,et al. Novel,single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired Pneumonia in adults. Antimicrob Agents Chemother,2005,49:4035-4041.
二级参考文献7
1Owens RC Jr, Am brose PG, Nightingale CH. Antibiotic Optimization. Concepts and Strategies in Clinical Practice [M].New York: Marced Dekker. 2005. 491-518.
3Wilson L, Allegra L, Huchon G, et al. Short-term and longterm outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis [J].Chest, 2004,125: 953-964.
4Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adult: a randomized trial [J]. JAMA,2003, 290:2588-2598.
5Dennesen PJ, van der Ven AJ, Kessels AG, et al. Resolution of infections parameters after antimicrobial therapy in patients with ventilator-associated pneumonia [J]. Am J Respir Crit Care Med, 2001,163:1371-1375.
6American Thoracic Society, Infectious Diseases Society.Guidelines for the management of adult with hospital-acquired,ventilator-associated, and healthcare-associated pneumonia [J]. Am J Respir Crit Care Med, 2005,171:388-416.
7Blumer JL. Single-dose azithromycin for the treatment of acute otitis media in children [J]. Current Ther Res, 2003, 64(SA) :A1-A421.
3Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with communityacquired pneumonia. Arch Intern Med,2004,164(6) :637 -44.
4Wilson R, Allegra L, Huchon G, et al. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. Chest, 2004,125 ( 3 ) : 953 - 64.
5陈灏珠.实用内科学.12版.北京:人民卫生出版社,2004:1662.
6Miravitlles M, Molina J, Brosa M. Clinical efficacy of moxifloxacin in the treatment of exacerbations of chronic bronchitis : a systematic review and meta-analysis. Arch Bronconeumol,2007,43 ( 1 ) :22 - 8.
7Finch R, Schtirmann D, Hoettken G, et al. Randomized controlled trial of sequential intravenous ( i. v. ) and oral moxitloxacin compared with sequential i. v. and oral co-Amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiting initial parenteral treatment. Antimicreb Agents Chemother,2002,46 ( 6 ) : 1746 - 54.
8Mandell LA,Wunderink RG, Anzueto A, et al. Infectious diseases society of America/American Thoracic Society consensus guidelines on the management of community - acquired pneumonia in adults[J]. Clin Infect Dis, 2007, 44 (Sup pl 2) : S27 -S72.
9American Thoracic Society. Guidelines for the management of adults with community acquired pneumonia [ J ]. Am J Respir Crit Care Med, 2001, 163 (7) : 1730- 1754.
10Wilson R, Allegra L, Huchon G, et al. Short- term and long- term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis [ J ]. Chest, 2004, 125 (3) : 953 - 964.
